Research output per year
Research output per year
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Adherence to protocols for the use of reversal agents in patients treated with direct oral anticoagulants
Mitrovic, D., van Elp, M., Visser, L., van Rein, N., van den Bemt, P., van Hulst, M., Dreijer, A., Lameijer, H., Veeger, N., Meijer, K. & van Roon, E., Jun-2023, In: Current Medical Research and Opinion. 39, 6, p. 865-871 7 p.Research output: Contribution to journal › Article › Academic › peer-review
-
The right time to measure anti-Xa activity in critical illness: pharmacokinetics of therapeutic dose nadroparin
Sytema, J. G., Loef, B. G., Loovers, H. M., Boer, M., Touw, D. J. & van Hulst, M., May-2023, In: Research and practice in thrombosis and haemostasis. 7, 4, 9 p., 100185.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile2 Downloads (Pure) -
Correction: Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings
de Jong, L. A., Groeneveld, J., Stevanovic, J., Rila, H., Tieleman, R. G., Huisman, M. V., Postma, M. J. & van Hulst, M., 31-Mar-2022, In: PLoS ONE. 17, 3, 5 p., e0266625.Research output: Contribution to journal › Erratum
Open AccessFile1 Citation (Scopus)6 Downloads (Pure) -
Cost-effectiveness analysis of quadrivalent and nonavalent human papillomavirus vaccines in Ethiopia
Wondimu, A., Postma, M. J. & van Hulst, M., 25-Mar-2022, In: Vaccine. 40, 14, p. 2161-2167 7 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile3 Citations (Scopus)41 Downloads (Pure) -
Cost-effectiveness of screening smokers and ex-smokers for lung cancer in the Netherlands in different age groups
Al Khayat, M. N. M. T., Eijsink, J. F. H., Postma, M. J., van de Garde, E. M. W. & van Hulst, M., Sept-2022, In: European Journal of Health Economics. 23, 7, p. 1221-1227 7 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile7 Citations (Scopus)14 Downloads (Pure)
Press/Media
-
Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients — the randomized, EU-wide, placebo-controlled, phase II study design of IXION
19/08/2022
1 item of Media coverage
Press/Media: Other › Academic